Showcasing Clinical Success of a Novel STMN2-Targeting ASO to Restore Functional Expression & Promote Motor Neuronal Repair
Time: 1:40 pm
day: Day Two Track B PM
Details:
- Outlining latest advancements in the QRL-201 program
- Achieving successful restoration of STATHMIN-2 expression in ALS patients
- Highlighting upcoming steps in the advancement of QRL-201 towards later phase studies
